Akoya Biosciences Inc (AKYA)
4.09
-0.04
(-0.85%)
USD |
NASDAQ |
May 07, 16:00
4.09
0.00 (0.00%)
After-Hours: 19:45
Akoya Biosciences Accounts Payable (Quarterly): 11.78M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 11.78M |
| September 30, 2023 | 11.89M |
| June 30, 2023 | 11.73M |
| March 31, 2023 | 8.683M |
| December 31, 2022 | 10.63M |
| September 30, 2022 | 8.172M |
| June 30, 2022 | 13.37M |
| Date | Value |
|---|---|
| March 31, 2022 | 11.52M |
| December 31, 2021 | 9.435M |
| September 30, 2021 | 4.071M |
| June 30, 2021 | 4.898M |
| March 31, 2021 | 5.776M |
| December 31, 2020 | 5.074M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
4.071M
Minimum
Sep 2021
13.37M
Maximum
Jun 2022
9.002M
Average
9.435M
Median
Dec 2021
Accounts Payable (Quarterly) Benchmarks
| Bruker Corp | 199.10M |
| Azenta Inc | 40.24M |
| Harvard Bioscience Inc | 5.554M |
| Bionano Genomics Inc | 10.38M |
| Singular Genomics Systems Inc | 2.587M |